PD-L1 is expressed on tumor cells and tumor-infiltrating immune cells [4], and on activated T cells, the binding of PD-L1 to its receptor PD-1, lowers the T cell immune responses and prevents elimination of tumor cells [22,23,24,25]. Here, PDCD1 is linked to neoplasm.